STEVANATO GROUP SPA (STVN) Stock Price & Overview
NYSE:STVN • IT0005452658
Current stock price
The current stock price of STVN is 14.99 USD. Today STVN is up by 2.39%. In the past month the price decreased by -3.91%. In the past year, price decreased by -25.16%.
STVN Key Statistics
- Market Cap
- 4.54B
- P/E
- 24.57
- Fwd P/E
- 20.11
- EPS (TTM)
- 0.61
- Dividend Yield
- 0.40%
STVN Stock Performance
STVN Stock Chart
STVN Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to STVN. When comparing the yearly performance of all stocks, STVN is a bad performer in the overall market: 86.96% of all stocks are doing better.
STVN Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to STVN. STVN has an average financial health and profitability rating.
STVN Earnings
On March 4, 2026 STVN reported an EPS of 0.18 and a revenue of 346.50M. The company beat EPS expectations (4.36% surprise) and beat revenue expectations (2.01% surprise).
STVN Forecast & Estimates
17 analysts have analysed STVN and the average price target is 28.76 USD. This implies a price increase of 91.84% is expected in the next year compared to the current price of 14.99.
For the next year, analysts expect an EPS growth of 21.82% and a revenue growth 9.27% for STVN
STVN Groups
Sector & Classification
STVN Financial Highlights
Over the last trailing twelve months STVN reported a non-GAAP Earnings per Share(EPS) of 0.61. The EPS increased by 10.42% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 11.79% | ||
| ROA | 5.5% | ||
| ROE | 9.41% | ||
| Debt/Equity | 0.25 |
STVN Ownership
STVN Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 18.72 | 176.784B | ||
| DHR | DANAHER CORP | 22.06 | 131.712B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 126.64 | 43.04B | ||
| A | AGILENT TECHNOLOGIES INC | 16.67 | 31.558B | ||
| WAT | WATERS CORP | 19.72 | 27.794B | ||
| IQV | IQVIA HOLDINGS INC | 12.85 | 27.351B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 25.03 | 23.745B | ||
| ILMN | ILLUMINA INC | 22.73 | 17.669B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 29.06 | 16.643B | ||
| MEDP | MEDPACE HOLDINGS INC | 25.84 | 12.597B | ||
| RVTY | REVVITY INC | 15.52 | 9.476B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 8.854B | ||
| TECH | BIO-TECHNE CORP | 22.85 | 8.052B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About STVN
Company Profile
Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The company is headquartered in Piombino Dese, Padova and currently employs 5,521 full-time employees. The company went IPO on 2021-07-16. The firm delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The firm operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
Company Info
IPO: 2021-07-16
STEVANATO GROUP SPA
Piombino Dese (Pd) Via Molinella, 17
Piombino Dese PADOVA IT
CEO: Franco Moro
Employees: 5521
Phone: 390499318173
STEVANATO GROUP SPA / STVN FAQ
What does STEVANATO GROUP SPA do?
Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The company is headquartered in Piombino Dese, Padova and currently employs 5,521 full-time employees. The company went IPO on 2021-07-16. The firm delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The firm operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
What is the stock price of STEVANATO GROUP SPA today?
The current stock price of STVN is 14.99 USD. The price increased by 2.39% in the last trading session.
Does STEVANATO GROUP SPA pay dividends?
STEVANATO GROUP SPA (STVN) has a dividend yield of 0.4%. The yearly dividend amount is currently 0.06.
How is the ChartMill rating for STEVANATO GROUP SPA?
STVN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
How is the market expecting STVN stock to perform?
17 analysts have analysed STVN and the average price target is 28.76 USD. This implies a price increase of 91.84% is expected in the next year compared to the current price of 14.99.
Is STEVANATO GROUP SPA (STVN) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on STVN.
What is the Short Interest ratio of STEVANATO GROUP SPA (STVN) stock?
The outstanding short interest for STEVANATO GROUP SPA (STVN) is 3.93% of its float.